Titelia

Holdings of Propel Bio Management, LLC

33 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 61.8 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 94.5 %
  • GB 2.8 %
  • FR 2.7 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US31139.9M $94.52 %
2GB14.1M $2.78 %
3FR14M $2.70 %

Positions

RankCompanySharesValueWeight
1Plains GP Holdings LP 1,272,36030.2M $
2ACHIEVE LIFE SCIENCES INC 3,786,42511.4M $
3Phathom Pharmaceuticals Inc 841,2729.4M $
4Delcath Systems Inc 979,6989.2M $
5Corcept Therapeutics Inc 147,8286M $
6Abeona Therapeutics Inc 1,329,8996M $
7Vor BioPharma Inc 314,5435.6M $
8Kyverna Therapeutics Inc 644,4215.6M $
9Celldex Therapeutics Inc 131,3644.1M $
10Compass Pathways plc 742,0494.1M $
11Viridian Therapeutics Inc 210,1634.1M $
12Inventiva SACA 724,6784M $
13SAB Biotherapeutics Inc 1,012,7903.9M $
14Orchestra BioMed Holdings Inc 896,7013.8M $
154D Molecular Therapeutics Inc 380,4203.6M $
16Ocular Therapeutix Inc 382,3753.2M $
17Upstream Bio Inc 341,7793.1M $
18Aquestive Therapeutics Inc 710,9883M $
19EyePoint Inc 215,8252.8M $
20Trevi Therapeutics Inc 223,8022.6M $
21Zevra Therapeutics Inc 282,4182.6M $
22IMMUNIC INC 2,344,7792.6M $
23Coherus Oncology Inc 1,420,5502.4M $
24Ovid therapeutics Inc 921,4572M $
25Palisade Bio Inc 1,115,0002M $
26KALARIS THERAPEUTICS INC 295,7711.7M $
27LeonaBio Inc 149,2791.5M $
28Nuvation Bio Inc 329,2961.4M $
29Maze Therapeutics Inc 43,7981.3M $
30Evommune Inc 55,6641.3M $
31Corvus Pharmaceuticals Inc 85,7911.3M $
32Aldeyra Therapeutics Inc 730,6061.2M $
33Artiva Biotherapeutics Inc 146,369949.8K $